Interv Akut Kardiol. 2021;20(2):69-72 | DOI: 10.36290/kar.2021.022

Pathology of covid-19

Václav Stejskal, Ivo Šteiner, Monika Manethová
Fingerlandův ústav patologie Lékařské fakulty UK a Fakultní nemocnice, Hradec Králové

In covid-19, the basic lesion is interstitial pneumonia presenting as diffuse alveolar damage. However, unlike DAD/ARDS from other causes, there are several rather specific histopathological features: in the lung parenchyma, there is frequently a combination of all stages of DAD - acute, subacute, and chronic; platelet, and fibrin-rich thrombi are found in all types of pulmonary vessels - microcirculation, arteries, and veins, with formation of lung infarctions; the inflammation has a marked hemorrhagic character - alveolar bleeding; presence of atypical activated type II pneumocytes; unusual ("naked") megakaryocytes within the microvasculature; presence of virions in lung cells; and tendency to bacterial or fungal superinfection. In the heart, no specific, reproducible histopathology of covid-19 myocardial injury has been shown at autopsy and the rates of fatal myocarditis are low.

Keywords: covid-19, pathology, lungs, DAD/ARDS, heart.

Published: July 9, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stejskal V, Šteiner I, Manethová M. Pathology of covid-19. Interv Akut Kardiol. 2021;20(2):69-72. doi: 10.36290/kar.2021.022.

Download citation

References

  1. Borczuk AC, Salvatore SP, Seshan SV, et al. Covid-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City. Mod Pathol 2020; 33: 2156-2168. Go to original source... Go to PubMed...
  2. Bösmüller H, Matter M, Fend F, et al. The pulmonary pathology of Covid-19. Virchows Arch 2021; 478: 137-150. Go to original source... Go to PubMed...
  3. Tabary M, Khanmohammadi S, Araghi F, et al. Pathologic features of covid-19: a concise review. Pathol Res Pract 2020; 216: Article 153097. Go to original source... Go to PubMed...
  4. Skok K, Vander K, Setaffy L, et al. Covid-19 autopsies: Procedure, technical aspects and cause of fatal course. Experiences from a single-center. Pathol Res Pract 2021; 217: Article 153305. Go to original source... Go to PubMed...
  5. Valdivia-Mazeyra MF, Salas C, Nieves-Alonso JM, et al. Increased number of pulmonary megakaryocytes in covid-19 patients with diffuse alveolar damage: an autopsy study with clinical correlation and review of the literature. Virchows Arch 2021; 478: 487-496. Go to original source... Go to PubMed...
  6. Zhoü F, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with covid-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-1062. Go to original source... Go to PubMed...
  7. Guan WJ, Ni ZY, HU Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-1720. Go to original source... Go to PubMed...
  8. Halushka MK, Vander Heide RS. Myocarditis is rare in covid-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol 2021; 50, 107300. Go to original source... Go to PubMed...
  9. Rapkiewicz AV, Mai X, Carsons SE, et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in covid-19: a case series. Clinical Medicine 2020; 24, 100434. Go to original source... Go to PubMed...
  10. Tombolini A, Scendoni R. SARS-Cov-2-related deaths in routine forensic autopsy practice: histopathological patterns. Int J Legal Med https://doi.org/10.1007/s00414-020-02354-5. Go to original source... Go to PubMed...
  11. Karetová D, Bultas J. Koagulopatie provázející těžší formy koronavirové infekce (covid-19) - incidence trombotických komplikací, jak jim předcházet a jak je léčit. Cor Vasa 2020; 62(Suppl. 1): 22-26. Go to original source...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.